Synaptic density (SV2A) tracks illness chronicity rather than symptom severity in major depressive disorder
- 1Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm
Abstract
Synaptic loss has been proposed as a key mechanism in major depressive disorder (MDD). Positron emission tomography with [11C]UCB-J enables in vivo quantification of synaptic vesicle glycoprotein 2A (SV2A), a proxy marker of synaptic density. A landmark study by Holmes et al reported an inverse association between depression severity and SV2A binding in frontolimbic regions. As a replication, we examined this association in [11C]UCB-J PET data from 34 unmedicated individuals with MDD, focusing on the dorsolateral prefrontal cortex, anterior cingulate cortex, and hippocampus. We found no support of an association between MADRS scores and SV2A binding in the primary regions of interest (r = 0.18-0.26, all p >= 0.15; 0.15). Findings were similar in unadjusted and age- and sex-adjusted models. However, adjustment for duration of the current depressive episode and lifetime depressive episodes yielded positive associations across primary regions. In post hoc analyses, longer current episode duration, but not lifetime depressive episodes, was negatively associated with SV2A binding across primary regions. Thus, our findings did not support an association between depression severity and synaptic density, contrary to a previous report; instead, the exploratory findings suggest that SV2A binding may be related to episode duration rather than current symptom burden.
Related
- Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study
- Depressive symptoms and fatigue are independently associated with myasthenia gravis-specific quality of life beyond neurological severity: a cross-sectional study
- Exploratory Imaging in SWEDD: Insights from Dopaminergic PET, Synaptic Density PET, and Volumetric MRI
- Pupil size-resting state network coupling in major depressive disorder: a longitudinal iTBS study
- Biologically informed network-regularized sparse consensus clustering (BioNet-SPACC) identifies a continuous plasma proteomic axis in major depressive disorder
BibTeX
@misc{yngwe2026synaptic,
title = {{Synaptic density (SV2A) tracks illness chronicity rather than symptom severity in major depressive disorder}},
author = {H. Yngwe and P. Plaven Sigray and M. Andersson and M. Bolin and M. Beckman and C.-J. Ekman and M. Tiger and J. Lundberg},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.27.26366602},
url = {https://www.medrxiv.org/content/10.64898/2026.10.27.26366602v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Synaptic density (SV2A) tracks illness chronicity rather than symptom severity in major depressive disorder
AU - H. Yngwe
AU - P. Plaven Sigray
AU - M. Andersson
AU - M. Bolin
AU - M. Beckman
AU - C.-J. Ekman
AU - M. Tiger
AU - J. Lundberg
PY - 2026
DA - 2026/10/27
PB - medRxiv
DO - 10.64898/2026.10.27.26366602
UR - https://www.medrxiv.org/content/10.64898/2026.10.27.26366602v1
AB - Synaptic loss has been proposed as a key mechanism in major depressive disorder (MDD). Positron emission tomography with [11C]UCB-J enables in vivo quantification of synaptic vesicle glycoprotein 2A (SV2A), a proxy marker of synaptic density. A landmark study by Holmes et al reported an inverse association between depression severity and SV2A binding in frontolimbic regions. As a replication, we examined this association in [11C]UCB-J PET data from 34 unmedicated individuals with MDD, focusing on the dorsolateral prefrontal cortex, anterior cingulate cortex, and hippocampus. We found no support of an association between MADRS scores and SV2A binding in the primary regions of interest (r = 0.18-0.26, all p >= 0.15; 0.15). Findings were similar in unadjusted and age- and sex-adjusted models. However, adjustment for duration of the current depressive episode and lifetime depressive episodes yielded positive associations across primary regions. In post hoc analyses, longer current episode duration, but not lifetime depressive episodes, was negatively associated with SV2A binding across primary regions. Thus, our findings did not support an association between depression severity and synaptic density, contrary to a previous report; instead, the exploratory findings suggest that SV2A binding may be related to episode duration rather than current symptom burden.
ER -